Webinar: Developing Cures with Less Time & Capital
The Myelin Repair Foundation, Ewing Marion Kauffman Foundation, Pioneer Portfolio of the Robert Wood Johnson Foundation, and the Scott Cook & Signe Ostby Foundation are offering an interactive Webinar to discuss a new drug development model with the potential to cut years from the drug development timeline, saving lives and money.
The webinar will focus on Myelin Repair Foundation’s new holistic approach to multiple sclerosis drug development that bridges the gap between the promising discoveries made in academic laboratories and big-pharmaceutical drug research and development. The approach shows early promise in cutting development costs and shaving years off of the time it takes to move a drug from basic science to patient therapy. The session will include an interactive Q&A portion where participants can direct questions to participating panelists.
Here are the details:
“Developing Cures with Less Time & Capital: A New Research Model to Accelerate Drug Development”
Thursday, March 25, 2010 - 1 p.m. EDT, Noon CDT, 10 a.m. PDT
Scott Johnson, President and Founder, Myelin Repair Foundation
Lesa Mitchell, Vice President, Advancing Innovation, Kauffman Foundation
Nancy Barrand, Special Advisor for Program Development, Robert Wood Johnson Foundation
Scott Cook, Co-founder of the Scott Cook & Signe Ostby Foundation and Co-founder of Intuit Inc.
719-325-2331 or toll-free, 888-430-8690 - Confirmation Code: 2798343
comments powered by